South America Diet Pills Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Prescription, Over the Counter Drugs, and Herbal Supplements), Application (Appetite Suppression, Fat Blocking, Metabolism Raising Pills, and Others), Age Group (Children and Adults), and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores)

The SAM diet pills market is expected to grow from US$ 76.11 million in 2021 to US$ 146.02 million by 2028; it is estimated to grow at a CAGR of 9.8% from 2021 to 2028.

Consumers choose online channels that provide more convenient and greater access to various brands. This encourages them to make bulk purchases and spend larger amounts. According to a survey, it was found that ~16.7% of diet supplements were made online in 2020, a 64% rise from 2019. The online category is estimated to register 25% of diet supplement sales by 2024. A few companies dominate the diet pills market; however, all market players have varied the distribution channels, as the internet reduced a few challenges to access these products. For instance, consumers have better access to health and nutrition information with active media telecasts, lifestyle blogs, and social media. Further, corporations are enhancing their advertising efforts and product development budgets. 

With the new features and technologies, vendors attract new customers to grow their footprints in emerging markets. This factor is likely to drive the SAM diet pills market. The SAM diet pills market is expected to grow at a substantial CAGR during the forecast period.

SAM Diet Pills Market Revenue and Forecast to 2028 (US$ Million)

SAM Diet Pills Market Segmentation

The SAM diet pills market is segmented into product type, application, age group, distribution channel, and country. Based on product type, the SAM diet pills market is segmented into prescription, herbal supplements, and over the counter drugs. The prescription segment dominated the market in 2020. Based on application, the SAM diet pills market is segmented into appetite suppression, fat blocking, metabolism raising pills, and others. The appetite suppression segment led the market in 2020. Based on age group, the SAM diet pills market is bifurcated into adults and teenagers. The adults segment dominated the market in 2020. Based on distribution channel, the SAM diet pills market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies & drug stores. The hospital pharmacies segment led the market in 2020. Based on country, the SAM diet pills market is segmented into Brazil, Argentina, and the Rest of SAM. The Brazil segment dominated the market in 2020.  

Pfizer Inc. (Arena Pharmaceutical GMBH), Novo Nordisk A/S, GlaxoSmithKline plc, Lovate Health Sciences International Inc., TEVA Pharmaceutical Industries LTD, and Chong’s Health Care are among the leading companies operating in the SAM diet pills market.

1. Pfizer Inc. (Arena Pharmaceutical GMBH)
2. Novo Nordisk A/S
3. GlaxoSmithKline plc
4. Lovate Health Sciences International Inc.
5. TEVA  Pharmaceutical Industries LTD
6. Chong’s Health Care

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM Diet pills market.      
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the SAM Diet pills market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the SAM Diet pills market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution